The ImmunoWELL VZV IgG Test is an ELISA method for the qualitative detection of IgG to Varicella Zoster virus (VZV). Test results are used as,an aid to determine immune status or infection. Immune st
...tBlot G Tests are qualitative enzyme immunoassays ...rgdorferi antibodies (IgG or IgM, respectively) in...ests should be supplemented with a standardized we...an be used to support a clinical diagnosis of B. b...
The ImmunoWELL TPO IgG Quantitative Test is a quantitative enzyme immunoassay (EIA) for screening and detection of autoantibodies against human thyroid peroxidase (microsome) in serum and is used as
The ImmunoDOT Autoimmunity Screening Panel 6 is an enzyme immunoassay (EIA) test for screening and detection of autoantibodies against various specific nuclear antigens (SS-A, SS-B, RNP/Sm, Sm, Jo-1,
Medicine Products:(Date:12/2/2008)...h differences between groups of immigrants in Oslo...so great. The differences are seen for risk factor...rt from the Norwegian Institute of Public Health. ... with each other and the ethnic Norwegian populati... health care better. , The five immigrant group...
(Date:12/2/2008)...ewswire/ -- Smile Reminder, the nation,s leading,...led the latest in industry,technology today at Ja...tool,for capturing and distributing video testimo...testimonials onto popular platforms such as YouTub...provides doctors with an effective,business strat...
(Date:12/2/2008)...sday, December 2, 2008 at 3 pm CST)--Radiology and...rsity of South Carolina in Charleston, S.C., today...om exposure to radiation during computed tomograph...nd that new estimates are several times lower than...rchers presented their findings at the annual mee...
(Date:12/2/2008)...s establish special bonds between partners. Oftent...rships, and ultimately, the start of families. , ...o much emotional weight on their relationship. As ...self-worth solely based on the outcomes of their r...erm as relationship-contingent self-esteem (RCSE),...
Breaking Medicine News(10 mins):Health News:Large health differences between population groups in Norway 2Health News:Large health differences between population groups in Norway 3Health News:Large health differences between population groups in Norway 4Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2Health News:Too much commitment may be unhealthy for relationships, UH psychology professor says 2(Date:12/1/2008)... Hypophosphatasia Treated With ENB-0040 at Childre..., , MONTREAL, Dec. 1 Enobia ...ed on developing novel therapeutics for serious bo...t patient in its clinical program for hypophosphat...lacement Therapy (ERT) with ENB-0040 for the treat...
(Date:12/1/2008)...Call Scheduled for Tuesday, December 9 at 11:00 am... , SOUTH SAN FRANCISCO, Calif., Dec. 1 /PR...c. (Nasdaq: SNSS ), a biopharmaceutical company ...f new oncology therapeutics, today announced new d... leukemia (AML) will be presented during the 50th ...
(Date:11/28/2008)...Germany, November 28 German biotec...ip in specialized HIV monitoring and,AIDS patient... countries. In,the year 2008, 2.5 million patient...ust and highly affordable "CyFlow" system, support...h HIV/AIDS. Due to introduction of the,Partec inn...
(Date:11/26/2008)... to 406 Subjects , , FRANKLIN, Mass., Nov. ... Bulletin Board: PLCSF) announced today that it ha...ug Administration (FDA) for its U.S. pivotal trial...Guard System(TM) and associated therapy in the pr... , The FDA also approved PLC,s request to ex...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Breakthroughs Offer Hope to MS Patients 23300 1Breakthroughs Offer Hope to MS Patients 23300 2Breakthroughs Offer Hope to MS Patients 23300 3Treatment delays result in poor outcomes for men with breast cancer 3900 1Treatment delays result in poor outcomes for men with breast cancer 3900 2Want to fly 3F Dont copy the birds and the bees 3898 1Want to fly 3F Dont copy the birds and the bees 3898 2Topical oral syrup prevents early childhood caries 23298 1...ademic Societies, Annual Meeting,This Month in Tor...etry Technology Can Reduce the Risk Associated wit...wire/ -- Masimo, the,inventor of Pulse CO-Oximetry...ximetry, reported that a new independent study,pre...Annual Meeting,in Toronto, Canada earlier this mon...
...ewswire-FirstCall/ -- IDM,Pharma, Inc. today annou...cine clinical trial and data from the Phase II EP-...inical trial will be,presented at the 2007 America...meeting in Chicago on June 1-5 2007. , , UVIDEM...unological responses in patients with malignant, ...
Other Medicine Technology:Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 2Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 3Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 4IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 2IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 3IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 4IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 5IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 6